In this report, our team offers a comprehensive analysis of Huntington Disease Protein market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain, market statistics in terms of revenue, sales, price, capacity, regional market analysis, segment-wise data, and market forecast information are offered in the full study, etc.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
AFFiRiS AG
Ionis Pharmaceuticals, Inc.
Neurimmune Holding AG
nLife Therapeutics, S.L.
reMYND NV
Sangamo BioSciences, Inc.
UniQure N.V.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
NI-302
NLF-HD
P-301905
IONIS-HTTRx
Others
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Alzheimer's Disease
Kennedy's Disease
Spinocerebellar Ataxia
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Huntington Disease Protein Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 NI-302
1.3.2 NLF-HD
1.3.3 P-301905
1.3.4 IONIS-HTTRx
1.3.5 Others
1.4 Application Overview
1.4.1 Alzheimer's Disease
1.4.2 Kennedy's Disease
1.4.3 Spinocerebellar Ataxia
1.4.4 Others
1.5 Industrial Chain
1.5.1 Huntington Disease Protein Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 NI-302
2.1.2 NLF-HD
2.1.3 P-301905
2.1.4 IONIS-HTTRx
2.1.5 Others
2.2 The Overall Market Performance(Value)
2.2.1 NI-302
2.2.2 NLF-HD
2.2.3 P-301905
2.2.4 IONIS-HTTRx
2.2.5 Others
3 Global Huntington Disease Protein Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Alzheimer's Disease
3.3 Kennedy's Disease
3.4 Spinocerebellar Ataxia
3.5 Others
4 Competitive Analysis
4.1 AFFiRiS AG
4.1.1 AFFiRiS AG Profiles
4.1.2 AFFiRiS AG Product Information
4.1.3 AFFiRiS AG Huntington Disease Protein Business Performance
4.1.4 SWOT Analysis
4.2 Ionis Pharmaceuticals, Inc.
4.2.1 Ionis Pharmaceuticals, Inc. Profiles
4.2.2 Ionis Pharmaceuticals, Inc. Product Information
4.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Business Performance
4.2.4 SWOT Analysis
4.3 Neurimmune Holding AG
4.3.1 Neurimmune Holding AG Profiles
4.3.2 Neurimmune Holding AG Product Information
4.3.3 Neurimmune Holding AG Huntington Disease Protein Business Performance
4.3.4 SWOT Analysis
4.4 nLife Therapeutics, S.L.
4.4.1 nLife Therapeutics, S.L. Profiles
4.4.2 nLife Therapeutics, S.L. Product Information
4.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Business Performance
4.4.4 SWOT Analysis
4.5 reMYND NV
4.5.1 reMYND NV Profiles
4.5.2 reMYND NV Product Information
4.5.3 reMYND NV Huntington Disease Protein Business Performance
4.5.4 SWOT Analysis
4.6 Sangamo BioSciences, Inc.
4.6.1 Sangamo BioSciences, Inc. Profiles
4.6.2 Sangamo BioSciences, Inc. Product Information
4.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Business Performance
4.6.4 SWOT Analysis
4.7 UniQure N.V.
4.7.1 UniQure N.V. Profiles
4.7.2 UniQure N.V. Product Information
4.7.3 UniQure N.V. Huntington Disease Protein Business Performance
4.7.4 SWOT Analysis
4.8 Voyager Therapeutics, Inc.
4.8.1 Voyager Therapeutics, Inc. Profiles
4.8.2 Voyager Therapeutics, Inc. Product Information
4.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Business Performance
4.8.4 SWOT Analysis
4.9 Vybion, Inc.
4.9.1 Vybion, Inc. Profiles
4.9.2 Vybion, Inc. Product Information
4.9.3 Vybion, Inc. Huntington Disease Protein Business Performance
4.9.4 SWOT Analysis
4.10 WAVE Life Sciences Ltd.
4.10.1 WAVE Life Sciences Ltd. Profiles
4.10.2 WAVE Life Sciences Ltd. Product Information
4.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Business Performance
4.10.4 SWOT Analysis
5 Competitive Lanscape
5.1 Global Huntington Disease Protein Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Huntington Disease Protein Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Huntington Disease Protein Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Huntington Disease Protein Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Huntington Disease Protein Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Huntington Disease Protein Market Assessment by Regions
7.1 Global Huntington Disease Protein Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Huntington Disease Protein Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Huntington Disease Protein Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Huntington Disease Protein Price (USD/Unit) by Regions (2014-2020)
7.5 Global Huntington Disease Protein Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.2 China Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.3 USA Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.4 Europe Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.5 Japan Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.6 Korea Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.7 India Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Huntington Disease Protein Capacity and Growth Rate (2014-2020)
8.9 South America Huntington Disease Protein Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Huntington Disease Protein Major Manufacturers
11 Global Huntington Disease Protein Market Forecast by Regions
11.1 Global Huntington Disease Protein Market Forecast (2021-2026)
11.1.1 Global Huntington Disease Protein Capacity Forecast by Regions (2021-2026)
11.1.2 Global Huntington Disease Protein Sales Forecast by Regions (2021-2026)
11.1.2 Global Huntington Disease Protein Revenue Forecast by Regions (2021-2026)
11.2 China Huntington Disease Protein Market Forecast (2021-2026)
11.3 USA Huntington Disease Protein Market Forecast (2021-2026)
11.4 Europe Huntington Disease Protein Market Forecast (2021-2026)
11.5 Japan Huntington Disease Protein Market Forecast (2021-2026)
11.6 Korea Huntington Disease Protein Market Forecast (2021-2026)
11.7 India Huntington Disease Protein Market Forecast (2021-2026)
11.8 Southeast Asia Huntington Disease Protein Market Forecast (2021-2026)
11.9 South America Huntington Disease Protein Market Forecast (2021-2026)
12 Global Huntington Disease Protein Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 NI-302
12.3 NLF-HD
12.4 P-301905
12.5 IONIS-HTTRx
12.6 Others
13 Global Huntington Disease Protein Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Alzheimer's Disease
13.3 Kennedy's Disease
13.4 Spinocerebellar Ataxia
13.5 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Huntington Disease Protein Average Price Forecast (2021-2026)
14.2 Global Huntington Disease Protein Gross Profit Forecast (2021-2026)
15 Conclusion